This patent covers the use of neural terminally differentiated teratocarcinoma cells (hNT) for the treatment of Huntington's disease. This technology has actually been used in clinical trials.
View this patent on the USPTO website.
You must be signed-in to add your comments.
Sign-in now or Join the StemCellPatents.com Community for free.